Related Experiment Video
Updated: Feb 16, 2026
12:24
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
6.2K
The NHS Bowel Cancer Screening Program: current perspectives on strategies for improvement.
Sara Koo1, Laura Jane Neilson1, Christian Von Wagner2
1Department of Gastroenterology, South Tyneside District Hospital, South Shields.
Risk Management and Healthcare Policy
|December 23, 2017
Summary
The English National Health Service Bowel Cancer Screening Program (BCSP) reduces colorectal cancer (CRC) mortality. Switching to fecal immunochemical tests (FIT) may further improve participation and outcomes.
Area of Science:
- Oncology
- Public Health
- Gastroenterology
Background:
- Colorectal cancer (CRC) is a leading cause of cancer death in the UK.
- The English National Health Service Bowel Cancer Screening Program (BCSP) aims to reduce CRC mortality through early detection.
- Current BCSP for ages 60-74 uses biennial guaiac fecal occult blood tests (gFOBt), with positive results leading to colonoscopy.
Purpose of the Study:
- To evaluate the impact of the BCSP on CRC mortality and diagnosis.
- To identify barriers to screening uptake.
- To explore the potential benefits of transitioning to fecal immunochemical tests (FIT).
Main Methods:
- Review of BCSP data and outcomes.
- Analysis of screening participation rates.
- Consideration of FIT as a replacement for gFOBt.
Main Results:
- BCSP has achieved a 15% reduction in CRC mortality.
- BCSP has led to a significant stage shift in CRC diagnosis.
- Screening uptake remains suboptimal compared to other programs.
Conclusions:
- The BCSP is effective in reducing CRC mortality and improving diagnostic stage.
- Further research is needed to understand and address low screening uptake.
- Transitioning to FIT kits in the BCSP could enhance patient participation and improve CRC outcomes.
